Literature DB >> 21389681

Turning the pyramid of prenatal care.

Kypros H Nicolaides1.   

Abstract

The current approach to prenatal care, which involves visits at 16, 24, 28, 30, 32, 34 and 36 weeks and then weekly until delivery, was established 80 years ago. The high concentration of visits in the third trimester implies, firstly, that most complications occur at this late stage of pregnancy and, secondly, that most adverse outcomes are unpredictable during the first or even second trimester. This review presents evidence that many pregnancy complications can now be predicted at an integrated first hospital visit at 11-13 weeks by combining data from maternal characteristics and history with findings of biophysical and biochemical tests. It is therefore proposed that the traditional pyramid of care should be inverted with the main emphasis placed in the first rather than third trimester of pregnancy.
Copyright © 2011 S. Karger AG, Basel.

Mesh:

Year:  2011        PMID: 21389681     DOI: 10.1159/000324320

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  43 in total

1.  Assessment of body composition in Wistar rat offspring by DXA in relation to prenatal and postnatal nutritional manipulation.

Authors:  Makarios Eleftheriades; Homeira Vafaei; Ismene Dontas; George Vaggos; Katerina Marinou; Panagiota Pervanidou; Neil J Sebire; George P Chrousos; Kypros H Nicolaides
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

2.  Assessment of Foetal DNA in Maternal Blood - A Useful Tool in the Hands of Prenatal Specialists.

Authors:  K O Kagan; M Hoopmann; P Kozlowski
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-11       Impact factor: 2.915

3.  Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy.

Authors:  Nobuhiro Suzumori; Takeshi Ebara; Takahiro Yamada; Osamu Samura; Junko Yotsumoto; Miyuki Nishiyama; Kiyonori Miura; Hideaki Sawai; Jun Murotsuki; Michihiro Kitagawa; Yoshimasa Kamei; Hideaki Masuzaki; Fumiki Hirahara; Juan-Sebastian Saldivar; Nilesh Dharajiya; Haruhiko Sago; Akihiko Sekizawa
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

4.  The use of ultrasound and other markers for early detection of preeclampsia.

Authors:  Neil O'Gorman; Kypros H Nicolaides; Liona C Y Poon
Journal:  Womens Health (Lond)       Date:  2016-02-22

Review 5.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

6.  Risk Assessment at 11-14-Week Antenatal Visit: A Tertiary Referral Center Experience from South India.

Authors:  Anusha Vellamkondu; Akhila Vasudeva; Rajeshwari G Bhat; Asha Kamath; Sapna V Amin; Lavanya Rai; Pratap Kumar
Journal:  J Obstet Gynaecol India       Date:  2017-04-08

7.  The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.

Authors:  Emily Suskin; Laura Hercher; Kathleen Erskine Aaron; Komal Bajaj
Journal:  J Genet Couns       Date:  2016-02-15       Impact factor: 2.537

Review 8.  Amniotic fluid stem cells to study mTOR signaling in differentiation.

Authors:  Margit Rosner; Katharina Schipany; Bharanidharan Shanmugasundaram; Gert Lubec; Oliver Brandau; Markus Hengstschläger
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

Review 9.  First trimester prediction of preeclampsia.

Authors:  Ulrik Dolberg Anderson; Magnus Gram; Bo Åkerström; Stefan R Hansson
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 10.  Understanding False Negative in Prenatal Testing.

Authors:  Mark I Evans; Ming Chen; David W Britt
Journal:  Diagnostics (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.